Literature DB >> 12428821

The associated reaction rating scale: a clinical tool to measure associated reactions in the hemiplegic upper limb.

Anne Macfarlane1, Lynne Turner-Stokes, Lorraine De Souza.   

Abstract

OBJECTIVE: To determine what items should be included in a clinical assessment tool developed to measure associated reactions in the hemiplegic upper limb and to assess the reliability of the resultant measure.
DESIGN: Development through a structured consultative process using focus group methodology. Evaluation of inter- and intra-rater reliability between two independent observers.
SUBJECTS: Nineteen consecutive hemiplegic patients admitted to Northwick Park Hospital for rehabilitation following stroke.
METHODS: Focus groups were conducted in two centres, comprising physiotherapists experienced in the clinical management of brain injury. The groups identified four key characteristics related to severity of associated reactions, which became the items of the rating scale. Evaluation of inter- and intra-rater reliability was undertaken by comparison of agreement between ratings of associated reactions occurring during a single standardized task (sit-to-stand), by two senior physiotherapists in 19 subjects.
RESULTS: There were good correlations between the two raters in total (rho 0.89 p < 0.005) and modal scores (rho 0.88 p < 0.005). Reliability testing of each item revealed moderate to very good inter-rater agreement (weighted kappa values 0.43-0.85) and good to very good intra-rater agreement (weighted kappa values 0.61-0.87). A slight tendency for one rater to score more severely than the other only reached significance for one item (excursion). Overall (modal) severity scores showed a good level of agreement (kappa 0.76-0.81) both between and within raters.
CONCLUSION: Items to be included in a clinical assessment tool to measure associated reactions in the hemiplegic upper limb were determined. Reliability of the resultant measure was found to be encouraging. These results however apply only to observations made during a specific standardized task (sit-to-stand) and further study of sensitivity to change and reproducibility in different tasks is required before the findings can be extrapolated into routine practice.

Entities:  

Mesh:

Year:  2002        PMID: 12428821     DOI: 10.1191/0269215502cr546oa

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  6 in total

1.  Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management.

Authors:  Lynne Turner-Stokes; Klemens Fheodoroff; Jorge Jacinto; Pascal Maisonobe
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

2.  Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice.

Authors:  Lynne Turner-Stokes; Klemens Fheodoroff; Jorge Jacinto; Pascal Maisonobe; Benjamin Zakine
Journal:  BMJ Open       Date:  2013-03-18       Impact factor: 2.692

3.  Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).

Authors:  Lynne Turner-Stokes; Stephen Ashford; Jorge Jacinto; Pascal Maisonobe; Jovita Balcaitiene; Klemens Fheodoroff
Journal:  BMJ Open       Date:  2016-06-17       Impact factor: 2.692

4.  Immediate effects of scapular stabilizing exercise in chronic stroke patient with winging and elevated scapula: a case study.

Authors:  Si-Eun Park; Yang-Rae Kim; Yong-Youn Kim
Journal:  J Phys Ther Sci       Date:  2018-01-27

5.  Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study.

Authors:  Lynne Turner-Stokes; Jorge Jacinto; Klemens Fheodoroff; Allison Brashear; Pascal Maisonobe; Andreas Lysandropoulos; Stephen Ashford
Journal:  J Rehabil Med       Date:  2021-01-01       Impact factor: 2.912

6.  Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.

Authors:  Lynne Turner-Stokes; Jorge Jacinto; Klemens Fheodoroff; Allison Brashear; Pascal Maisonobe; Andreas Lysandropoulos; Stephen Ashford
Journal:  J Rehabil Med       Date:  2021-02-24       Impact factor: 2.912

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.